Potential treatment of COVID-19, with the understanding of the role of ACE2 as a receptor for SARS-CoV-2, could include inhibition of the ACE2 receptor, spike protein-based vaccine, inhibition of transmembrane protease activity, or administration of soluble ACE2 (Cheng et al., 2020). Here, ACE2 is linked to COVID-19.